Eli Lilly and Company company info

What does Eli Lilly and Company do?

Eli Lilly (NYSE:LLY) is a global healthcare leader that specializes in creating high-quality medicines for multiple therapeutic areas. Engaging in comprehensive drug discovery to drive innovation, the company organizes its operations across human pharmaceutical products and animal health products divisions. Its projects primarily involve research, development, manufacturing and marketing operations. The company aims to offer successful medical breakthroughs, addressing severe health challenges, and assisting healthcare professionals in providing better treatments globally. Eli Lilly’s objectives include saving and improving lives, enhancing shareholder value through business growth and sustainability.
Eli Lilly and Company company media

Company Snapshot

Is Eli Lilly and Company a public or private company?

key

Ownership

Public

How many people does Eli Lilly and Company employ?

people

Employees

42,001

What sector is Eli Lilly and Company in?

pie chart

Sector

Health Care

Where is the head office for Eli Lilly and Company?

location pin

Head Office

Indianapolis, United States

What year was Eli Lilly and Company founded?

founded flag

Year Founded

1876

What does Eli Lilly and Company specialise in?

/Pharmaceutical Products /Medical Research /Diabetes Care /Oncology Treatments /Animal Health /Human Vaccines

What are the products and/or services of Eli Lilly and Company?

Overview of Eli Lilly and Company offerings
Insulin Glargine injection, an advanced insulin therapy, stands as a milestone in a patient's disease management journey.
Taltz, a revolutionary plaque psoriasis treatment provides a beacon of hope for those seeking better skin health.
Cyramza, a targeted therapy for stomach and lung cancers.
Alimta, an innovative chemotherapy medicine for treating mesothelioma and non-small cell lung cancer.
Strattera, a non-stimulant medicine is a diverse treatment option for attention deficit hyperactivity disorder (ADHD).
Portrazza presents a major breakthrough in the treatment of metastatic squamous non-small cell lung cancer.

Who is in the executive team of Eli Lilly and Company?

Eli Lilly and Company leadership team
  • Photo of Mr. David A. Ricks
    Mr. David A. Ricks
    Chairman, CEO & President
  • Photo of Dr. Daniel M. Skovronsky M.D., Ph.D.
    Dr. Daniel M. Skovronsky M.D., Ph.D.
    EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology
  • Photo of Ms. Anat  Hakim J.D.
    Ms. Anat Hakim J.D.
    Executive VP, General Counsel & Secretary
  • Photo of Mr. Jacob S. Van Naarden
    Mr. Jacob S. Van Naarden
    Executive VP & President of Loxo
  • Photo of Mr. Lucas E. Montarce
    Mr. Lucas E. Montarce
    Executive VP & CFO
  • Photo of Mr. Donald A. Zakrowski
    Mr. Donald A. Zakrowski
    Senior VP of Finance & Chief Accounting Officer
  • Photo of Mr. Diogo  Rau
    Mr. Diogo Rau
    EVP & Chief Information and Digital Officer
  • Photo of Mr. Eric  Dozier
    Mr. Eric Dozier
    Executive Vice President of Human Resources & Diversity